Valuation Imexpharm Corporation

Stocks

End-of-day quote Ho Chi Minh S.E. 2026-09-10			5-day change	1st Jan Change
38,100.00 ^VND	-1.80%		-4.27%	-27.43%

07-19	Imexpharm Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-01	Imexpharm Corporation Announces Cash Dividend for the Year 2025, Payable on July 21, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027
Market Cap ¹	5,187,048	4,013,628	3,962,167	7,238,421	8,085,471	5,867,741	-
Change	-	-22.62%	-1.28%	82.69%	11.7%	-27.43%	-
Enterprise Value (EV)	5,187,048	4,013,628	3,962,167	7,238,421	8,085,471	5,867,741	5,867,741
Change	-	-22.62%	-1.28%	82.69%	11.7%	-27.43%	0%
P/E	29.9x	17.2x	15.6x	24.3x	26.6x	16.5x	15.2x
PBR	2.89x	2.11x	1.9x	3.32x	-	2.34x	2.14x
PEG	-	0.5x	1.68x	1.4x	11.68x	1x	1.8x
Capitalization / Revenue	4.1x	2.44x	1.99x	3.28x	3.31x	2.21x	2.04x
EV / Revenue	0x	0x	0x	0x	0x	2.21x	2.04x
EV / EBITDA	-	-	-	-	-	-	-
EV / EBIT	0x	0x	0x	0x	0x	12x	11x
EV / FCF	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-
Dividend per Share ²	649.4	-	-	500	-	1,000	1,000
Rate of return	1.93%	-	-	1.06%	-	2.62%	2.62%
EPS ²	1,126	1,513	1,653	1,932	1,976	2,304	2,499
Distribution rate	57.7%	-	-	25.9%	-	43.4%	40%
Net sales ¹	1,266,597	1,643,707	1,994,037	2,205,120	2,441,085	2,659,000	2,881,000
EBITDA	299,271	-	457,049	521,703	-	-	-
EBIT ¹	234,475	300,992	374,407	403,285	445,003	490,000	532,000
Net income ¹	189,095	233,964	299,556	320,862	349,138	394,000	428,000
Net Debt	-	-	-	-	-	-	-
Reference price ²	33,679.65	26,060.61	25,727.27	47,000.00	52,500.00	38,100.00	38,100.00
Nbr of stocks (in thousands)	154,011	154,011	154,007	154,009	154,009	154,009	-
Announcement Date	1/20/22	1/17/23	1/19/24	1/20/25	1/20/26	-	-

¹VND in Million²VND

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
IMEXPHARM CORPORATION	16.84x	-	-	-	231M
ELI LILLY AND COMPANY	32x	11.63x	23.59x	0.62%	1,002B
JOHNSON & JOHNSON	28.37x	6.53x	17.91x	2.01%	644B
ABBVIE INC.	32.13x	7.46x	15.49x	2.73%	443B
ROCHE HOLDING AG	18.9x	4.61x	11.42x	2.88%	343B
NOVARTIS AG	19.46x	5.11x	12.69x	3.2%	262B
ASTRAZENECA PLC	20.29x	4.17x	11.93x	2.12%	245B
AMGEN INC.	24.75x	6.5x	11.57x	2.58%	212B
NOVO NORDISK A/S	12.86x	4.67x	9.75x	3.91%	199B
GILEAD SCIENCES, INC.	-44.5x	6.43x	25.11x	2.26%	181B
Average	16.11x	6.35x	15.50x	2.48%	352.99B
Weighted average by Cap.	22.91x	7.53x	17.31x	2.04%